Case number 2:20-cv-14833
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AUROBINDO PHARMA LTD. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2021 | N/A | Order Reassigning Case (0) Docket Text: TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Julien Xavier Neals for all further proceedings. Judge Madeline Cox Arleo no longer assigned to case. So Ordered by Chief Judge Freda L. Wolfson on 7/9/2021. (ams, ) |
| Feb 3, 2021 | 21 | Answer to Counterclaim (18) Docket Text: ANSWER to Counterclaim by All Plaintiffs.(WALSH, LIZA) |
| Jan 8, 2021 | 20 | Order (2) Docket Text: ORDER Consolidating Cases for All Purposes; All filings going forward shall be filed in Civil Action No. 20-10172 and that Civil Action Nos. 20-14890 and 20-14833 shall be administratively terminated. Signed by Magistrate Judge Michael A. Hammer on 1/8/2021. (ams, ) |
| Jan 8, 2021 | 19 | proposed Order of Consolidation (2) |
| Jan 8, 2021 | 19 | Letter (1) Docket Text: Letter from Liza M. Walsh to the Hon. Michael A. Hammer, U.S.M.J. encl. proposed Order of Consolidation. (Attachments: # (1) proposed Order of Consolidation)(WALSH, LIZA) |
| Jan 8, 2021 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated pursuant to [20] Order. (ams, ) |
| Jan 5, 2021 | N/A | Order (0) Docket Text: TEXT ORDER: Counsel for Aurobindo is granted leave to participate in the Rule 16 scheduling conference in Civ. No. 20-10172 and 20-14890 today at 11:00 a.m., for the purpose of addressing possible consolidation of these matters. So Ordered by Magistrate Judge Michael A. Hammer on 1/5/2021. (Hammer, Michael) |
| Jan 5, 2021 | N/A | Order (0) Docket Text: TEXT ORDER: The parties are directed to file a proposed order of consolidation by the close of business on January 8, 2021. So Ordered by Magistrate Judge Michael A. Hammer on 1/5/21. (TAD) |
| Dec 30, 2020 | 12 | Answer to Complaint (30) Docket Text: ANSWER to Complaint , COUNTERCLAIM against All Plaintiffs by All Defendants.(CASIERI, CHRISTOPHER) |
| Dec 30, 2020 | 13 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by AUROBINDO PHARMA LTD.. (CASIERI, CHRISTOPHER) |
| Dec 30, 2020 | 14 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by AUROBINDO PHARMA USA, INC.. (CASIERI, CHRISTOPHER) |
| Dec 30, 2020 | 15 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by AUROLIFE PHARMA LLC. (CASIERI, CHRISTOPHER) |
| Dec 30, 2020 | 16 | Letter (3) Docket Text: Letter from Liza M. Walsh to Hon. Michael A. Hammer. (Attachments: # (1) Text of Proposed Order)(WALSH, LIZA) |
| Dec 30, 2020 | 16 | Text of Proposed Order (3) |
| Dec 23, 2020 | N/A | QC - Incorrect Event Selected (0) Docket Text:CLERK'S QUALITY CONTROL MESSAGE - The [11] 6.1 Application filed by Christopher Casieri on 12/22/2020 was submitted incorrectly as a Motion. For future filings of this nature, please use the event "Application for Clerk Order to Ext Answer/Proposed Order" found under Other Documents. This submission will remain on the docket unless otherwise ordered by the court. (ams, ) |
| Dec 22, 2020 | 11 | Motion for Extension of Time to File Answer (1) Docket Text: First MOTION for Extension of Time to File Answer by All Defendants. (CASIERI, CHRISTOPHER) |
| Oct 28, 2020 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., NORTON (WATERFORD) LTD.. AUROBINDO PHARMA LTD. waiver sent on 10/23/2010, answer due 12/22/2010. (WALSH, LIZA) |
| Oct 28, 2020 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., NORTON (WATERFORD) LTD.. AUROBINDO PHARMA USA, INC. waiver sent on 10/23/2020, answer due 12/22/2020. (WALSH, LIZA) |
| Oct 28, 2020 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., NORTON (WATERFORD) LTD.. AUROLIFE PHARMA LLC waiver sent on 10/23/2020, answer due 12/22/2020. (WALSH, LIZA) |
| Oct 26, 2020 | 6 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by KATELYN O'REILLY on behalf of NORTON (WATERFORD) LTD., TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. (O'REILLY, KATELYN) |
| Oct 26, 2020 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by WILLIAM T. WALSH, JR on behalf of NORTON (WATERFORD) LTD., TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. (WALSH, WILLIAM) |
| Oct 23, 2020 | N/A | QC - Incorrect Entry made by Clerk's Office Staff (0) Docket Text:CLERK'S QUALITY CONTROL MESSAGE - Please note the AO121 Copyright Form filed by the Clerk's office on 10/23/2020 was docketed in error. Please disregard. (ams, ) |
| Oct 23, 2020 | 3 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ams, ) |
| Oct 23, 2020 | 4 | AO121 Copyright Form (1) Docket Text: AO121 Copyright Form filed. (ams, ) |
| Oct 23, 2020 | 5 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent/Trademark Form filed. (Attachments: # (1) Complaint and Exhibits) (ams, ) |
| Oct 23, 2020 | 5 | Complaint and Exhibits (276) |
| Oct 22, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Madeline Cox Arleo and Magistrate Judge Michael A. Hammer. (ak, ) |
| Oct 22, 2020 | 2 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by NORTON (WATERFORD) LTD., TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.. (WALSH, LIZA) |
| Oct 22, 2020 | 1 | AO120 Form (2) (1) |
| Oct 22, 2020 | 1 | AO120 Form (1) (1) |
| Oct 22, 2020 | 1 | Civil Cover Sheet (1) |
| Oct 22, 2020 | 1 | Exhibit A-G (226) |
| Oct 22, 2020 | 1 | Complaint* (1) |
